DD Support Board and Research Team

[DragonBear]

The "failed drug" you refer to (Ampligen)

just got designated as an orphan drug to treat Ebola by the European Medicines Agency.

Which means it now gets to undergo clinical trials. Where "failed drug" is still a possibility. Pretending that Ampligen is a "successful" drug on the cusp of being marketed just because it has EMA orphan status, is rather misleading for HEB or anyone else to state.

HEB can cackle all it wants to about 10 yrs exclusive marketing rights, trying to light up "$" signs in the eyes of investors. It's not going to market anything until EMA approval is given to market the drug. And that will come after HEB initiates, and successfully completes clinical trials. Where is there an announced clinical trial for Ampligen in humans? There seems to be none.